Further to the initiation of the share buy-back programme announced on 10 August 2016, Ageas reports the purchase of 209,280 Ageas shares on NYSE Euronext Brussels in the period from 20-03-2017 until 24-03-2017.

Date Number of
Shares		 Total amount
(EUR)		 Average price
(EUR)		 Lowest price
(EUR)		 Highest price
(EUR)
20-03-2017 10,000 372,618 37.26 37.18 37.36
21-03-2017 19,280 714,619 37.07 36.86 37.43
22-03-2017 60,000 2,177,268 36.29 36.04 36.70
23-03-2017 60,000 2,175,168 36.25 36.11 36.41
24-03-2017 60,000 2,165,508 36.09 35.99 36.33
Total 209,280 7,605,181 36.34 35.99 37.43

Since the start of the share buy-back programme on 15 August 2016, Ageas has bought back 4,486,366 shares for a total amount of EUR 157,756,251. This corresponds to 2.07% of the total shares outstanding.

The overview relating to the share buy-back programme is available on our website.

Ageas is a listed international insurance Group with a heritage spanning 190 years. It offers Retail and Business customers Life and Non-Life insurance products designed to suit their specific needs, today and tomorrow. As one of Europe's larger insurance companies, Ageas concentrates its activities in Europe and Asia, which together make up the major part of the global insurance market. It operates successful insurance businesses in Belgium, the UK, Luxembourg, France, Italy, Portugal, Turkey, China, Malaysia, India, Thailand, Vietnam, Laos, Cambodia, Singapore, and the Philippines through a combination of wholly owned subsidiaries and long term partnerships with strong financial institutions and key distributors. Ageas ranks among the market leaders in the countries in which it operates. It represents a staff force of over 40,000 people and reported annual inflows close to EUR 32 billion in 2016 (all figures at 100%).


Pdf version of the press release


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ageas via Globenewswire